Vitruvian Partners LLP Takes Position in MaxCyte, Inc. $MXCT
MarketBeat
Vitruvian Partners LLP bought a new stake in shares of MaxCyte, Inc. (NASDAQ:MXCT - Free Report) during the 2nd quarter, according to its most recent filing with the SEC. The firm bought 5,043,356 shares of the company's stock, valued at approximately $6,203,328,000. MaxCyte accounts for 3.1% of V
NASDAQ:MXCT